It is well established that elderly individuals are at increased risk of cognitive decline after anesthesia or surgery ( Moller et al., 1998 Rasmussen et al., 2003 Monk et al., 2008). Sporadic AD is multifactorial and may involve several different etiopathogenic mechanisms. The majority of AD cases have the sporadic form of the disease. The hyperphosphorylated tau loses its activity to bind to microtubules and to promote microtubule assembly, and instead disrupts microtubules ( Iqbal et al., 1986, 2010). The major brain pathological hallmarks of AD are extracellular senile plaques comprised predominantly of amyloid-β (Aβ) peptides, and intraneuronal neurofibrillary tangles (NTFs) comprised of abnormally hyperphosphorylated tau. These findings provide the first evidence supporting that intranasal insulin administration might be used for the prevention of anesthesia-induced cognitive decline and increased risk for AD and dementia.Īlzheimer’s disease (AD) is the most common form of dementia in adults, which accounts for an estimated 60 to 80% of dementia cases ( Thies and Bleiler, 2013). Intranasal insulin also resulted in down-regulation of several tau protein kinases, including cyclin-dependent protein kinase 5, calcium/calmodulin-dependent protein kinase II, and c-Jun N-terminal kinase.Ĭonclusion: Our results demonstrate that pretreatment with intranasal insulin prevents AD-like tau hyperphosphorylation. Intranasal administration of insulin attenuated propofol-induced hyperphosphorylation of tau, promoted brain insulin signaling, and led to up-regulation of protein phosphatase 2A, a major tau phosphatase in the brain.

Results: Propofol strongly promoted hyperphosphorylation of tau at several AD-related phosphorylation sites. Tau phosphorylation and tau protein kinases and phosphatases in the brains of mice 30 min and 2 h after propofol injection were then investigated by using Western blots and immunohistochemistry. The insulin- and control-treated mice were then anesthetized with single intraperitoneal injection of propofol (250 mg/kg body weight). Methods: We treated 3xTg-AD mice, a commonly used transgenic mouse model of AD, with daily intranasal administration of insulin (1.75 U/day) for one week. Recent studies suggest that anesthesia may increase the risk for cognitive decline and AD through promoting abnormal hyperphosphorylation of tau, which is crucial to neurodegeneration seen in AD.

General anesthesia is believed to be a risk factor for Alzheimer’s disease (AD). Background: It is well documented that elderly individuals are at increased risk of cognitive decline after anesthesia.

Veh2 samples